annual CFI:
-$84.00M-$278.00M(-143.30%)Summary
- As of today (September 16, 2025), RCUS annual cash flow from investing activities is -$84.00 million, with the most recent change of -$278.00 million (-143.30%) on December 31, 2024.
- During the last 3 years, RCUS annual CFI has fallen by -$80.00 million (-2000.00%).
- RCUS annual CFI is now -143.30% below its all-time high of $194.00 million, reached on December 31, 2023.
Performance
RCUS Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$137.00M+$105.00M(+328.13%)Summary
- As of today (September 16, 2025), RCUS quarterly cash flow from investing activities is $137.00 million, with the most recent change of +$105.00 million (+328.13%) on June 30, 2025.
- Over the past year, RCUS quarterly CFI has increased by +$74.00 million (+117.46%).
- RCUS quarterly CFI is now at all-time high.
Performance
RCUS quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$191.00M+$74.00M(+63.25%)Summary
- As of today (September 16, 2025), RCUS TTM cash flow from investing activities is $191.00 million, with the most recent change of +$74.00 million (+63.25%) on June 30, 2025.
- Over the past year, RCUS TTM CFI has increased by +$258.00 million (+385.07%).
- RCUS TTM CFI is now -15.11% below its all-time high of $225.00 million, reached on June 30, 2023.
Performance
RCUS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
RCUS Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -143.3% | +117.5% | +385.1% |
| 3 y3 years | -2000.0% | +163.7% | +134.6% |
| 5 y5 years | -241.9% | +257.3% | +764.2% |
RCUS Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -143.3% | +79.7% | at high | +163.7% | -15.1% | +134.6% |
| 5 y | 5-year | -143.3% | +80.7% | at high | +135.4% | -15.1% | +134.6% |
| alltime | all time | -143.3% | +80.7% | at high | +135.4% | -15.1% | +134.6% |
RCUS Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $137.00M(+328.1%) | $191.00M(+63.2%) |
| Mar 2025 | - | $32.00M(-37.3%) | $117.00M(-239.3%) |
| Dec 2024 | -$84.00M(-143.3%) | $51.00M(-275.9%) | -$84.00M(-21.5%) |
| Sep 2024 | - | -$29.00M(-146.0%) | -$107.00M(+59.7%) |
| Jun 2024 | - | $63.00M(-137.3%) | -$67.00M(-35.6%) |
| Mar 2024 | - | -$169.00M(-703.6%) | -$104.00M(-153.6%) |
| Dec 2023 | $194.00M(-147.0%) | $28.00M(+154.5%) | $194.00M(-8.9%) |
| Sep 2023 | - | $11.00M(-57.7%) | $213.00M(-5.3%) |
| Jun 2023 | - | $26.00M(-79.8%) | $225.00M(-1506.3%) |
| Mar 2023 | - | $129.00M(+174.5%) | -$16.00M(-96.1%) |
| Dec 2022 | -$413.00M(>+9900.0%) | $47.00M(+104.3%) | -$413.00M(-6.4%) |
| Sep 2022 | - | $23.00M(-110.7%) | -$441.22M(-20.2%) |
| Jun 2022 | - | -$215.00M(-19.8%) | -$552.83M(+65.1%) |
| Mar 2022 | - | -$268.00M(-1526.9%) | -$334.83M(+8270.7%) |
| Dec 2021 | -$4.00M | $18.78M(-121.2%) | -$4.00M(-82.3%) |
| Sep 2021 | - | -$88.61M(-3050.7%) | -$22.65M(-92.9%) |
| Jun 2021 | - | $3.00M(-95.2%) | -$321.15M(-21.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $62.83M(>+9900.0%) | -$411.23M(-5.2%) |
| Dec 2020 | -$434.00M(-833.0%) | $136.00K(-100.0%) | -$434.00M(-2.7%) |
| Sep 2020 | - | -$387.12M(+344.6%) | -$446.24M(+1451.8%) |
| Jun 2020 | - | -$87.07M(-317.4%) | -$28.76M(-133.8%) |
| Mar 2020 | - | $40.06M(-430.9%) | $84.99M(+43.5%) |
| Dec 2019 | $59.21M(-152.2%) | -$12.10M(-139.9%) | $59.21M(-19.8%) |
| Sep 2019 | - | $30.36M(+13.8%) | $73.83M(-285.2%) |
| Jun 2019 | - | $26.67M(+86.8%) | -$39.87M(-51.8%) |
| Mar 2019 | - | $14.28M(+468.7%) | -$82.67M(-27.1%) |
| Dec 2018 | -$113.44M(+131.2%) | $2.51M(-103.0%) | -$113.44M(-28.2%) |
| Sep 2018 | - | -$83.34M(+416.9%) | -$158.02M(+155.1%) |
| Jun 2018 | - | -$16.12M(-2.2%) | -$61.95M(+26.2%) |
| Mar 2018 | - | -$16.49M(-60.8%) | -$49.07M(-0.0%) |
| Dec 2017 | -$49.07M(+26.3%) | -$42.07M(-430.4%) | -$49.07M(+600.5%) |
| Sep 2017 | - | $12.73M(-492.6%) | -$7.00M(-64.5%) |
| Jun 2017 | - | -$3.24M(-80.3%) | -$19.74M(+19.7%) |
| Mar 2017 | - | -$16.49M | -$16.49M |
| Dec 2016 | -$38.86M | - | - |
FAQ
- What is Arcus Biosciences, Inc. annual cash flow from investing activities?
- What is the all time high annual CFI for Arcus Biosciences, Inc.?
- What is Arcus Biosciences, Inc. annual CFI year-on-year change?
- What is Arcus Biosciences, Inc. quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Arcus Biosciences, Inc.?
- What is Arcus Biosciences, Inc. quarterly CFI year-on-year change?
- What is Arcus Biosciences, Inc. TTM cash flow from investing activities?
- What is the all time high TTM CFI for Arcus Biosciences, Inc.?
- What is Arcus Biosciences, Inc. TTM CFI year-on-year change?
What is Arcus Biosciences, Inc. annual cash flow from investing activities?
The current annual CFI of RCUS is -$84.00M
What is the all time high annual CFI for Arcus Biosciences, Inc.?
Arcus Biosciences, Inc. all-time high annual cash flow from investing activities is $194.00M
What is Arcus Biosciences, Inc. annual CFI year-on-year change?
Over the past year, RCUS annual cash flow from investing activities has changed by -$278.00M (-143.30%)
What is Arcus Biosciences, Inc. quarterly cash flow from investing activities?
The current quarterly CFI of RCUS is $137.00M
What is the all time high quarterly CFI for Arcus Biosciences, Inc.?
Arcus Biosciences, Inc. all-time high quarterly cash flow from investing activities is $137.00M
What is Arcus Biosciences, Inc. quarterly CFI year-on-year change?
Over the past year, RCUS quarterly cash flow from investing activities has changed by +$74.00M (+117.46%)
What is Arcus Biosciences, Inc. TTM cash flow from investing activities?
The current TTM CFI of RCUS is $191.00M
What is the all time high TTM CFI for Arcus Biosciences, Inc.?
Arcus Biosciences, Inc. all-time high TTM cash flow from investing activities is $225.00M
What is Arcus Biosciences, Inc. TTM CFI year-on-year change?
Over the past year, RCUS TTM cash flow from investing activities has changed by +$258.00M (+385.07%)